Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Cloos

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Plos One|September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresMarcel Kool, Jan Koster, Jens Bunt, et al.
British Journal of Haematology|June 26, 2014
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapseCosta Bachas, Gerrit Jan Schuurhuis, Dirk Reinhardt, et al.
Leukemia|January 25, 2024
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemiaJesse M Tettero, Maaike E Heidinga, Tim R Mocking, et al.
American Journal of Hematology|September 6, 2023
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panelFarhad Ravandi, Jacqueline Cloos, Francesco Buccisano, et al.
Cytometry. Part B, Clinical Cytometry|September 28, 2023
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometryJesse M Tettero, Naveen Dakappagari, Maaike E Heidinga, et al.
Oncotarget|June 29, 2016
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemiaLonneke J Verboon, Askar Obulkasim, Jasmijn D E de Rooij, et al.
Ebiomedicine|August 20, 2015
Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progressionIrsan E Kooi, Berber M Mol, Annette C Moll, et al.
Cancer Medicine|December 25, 2021
The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzedKaterina Bakunina, Hein Putter, Jurjen Versluis, et al.
Genes, Chromosomes & Cancer|November 20, 2013
High resolution SNP array profiling identifies variability in retinoblastoma genome stabilityBerber M Mol, Maarten P G Massink, Annemarie H van der Hout, et al.
Scientific Reports|April 30, 2016
Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changesIrsan E Kooi, Berber M Mol, Maarten P G Massink, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Plos One|September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresMarcel Kool, Jan Koster, Jens Bunt, et al.
British Journal of Haematology|June 26, 2014
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapseCosta Bachas, Gerrit Jan Schuurhuis, Dirk Reinhardt, et al.
Leukemia|January 25, 2024
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemiaJesse M Tettero, Maaike E Heidinga, Tim R Mocking, et al.
American Journal of Hematology|September 6, 2023
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panelFarhad Ravandi, Jacqueline Cloos, Francesco Buccisano, et al.
Cytometry. Part B, Clinical Cytometry|September 28, 2023
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometryJesse M Tettero, Naveen Dakappagari, Maaike E Heidinga, et al.
Oncotarget|June 29, 2016
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemiaLonneke J Verboon, Askar Obulkasim, Jasmijn D E de Rooij, et al.
Ebiomedicine|August 20, 2015
Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progressionIrsan E Kooi, Berber M Mol, Annette C Moll, et al.
Cancer Medicine|December 25, 2021
The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzedKaterina Bakunina, Hein Putter, Jurjen Versluis, et al.
Genes, Chromosomes & Cancer|November 20, 2013
High resolution SNP array profiling identifies variability in retinoblastoma genome stabilityBerber M Mol, Maarten P G Massink, Annemarie H van der Hout, et al.
Scientific Reports|April 30, 2016
Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changesIrsan E Kooi, Berber M Mol, Maarten P G Massink, et al.
Pageof 18